Computed Tomography Angiography in Hyperacute Ischemic Stroke
Stroke 44:1480-1488, Mortimer, A.,et al, 2013
Magnetic Resonance Imaging or Computed Tomography for Suspected Acute Stroke: Association of Admission Image Modality with Acute Recanalization Therapies, Workflow Metrics, and Outcomes
Ann Neurol 92:184-194, Fischer, U.,et al, 2022
Functional Neurological Disorder
Stroke 51:1629-1635, Popkirov, S., et al, 2020
Reversible Diffusion-Weighted Imaging Lesions in Acute Ischemic Stroke
Neurol 94:571-587, Nagaraja, N.,et al, 2020
Thrombolysis for Acute Ischemic Stroke in the Unwitnessed or Extended Therapeutic Time Window
Neurol 94:e1241-e1248, Tsivgoulis, G.,et al, 2020
Intravenous Alteplase for Stroke with Unknown Time of Onset Guided by Advanced Imaging:Systematic Review and Meta-Analysis of Individual Patient Data
Lancet 396:1574-1585, Thomalla,G.,et al, 2020
Multimodal CT or MRI for IV thrombolysis in ischemic stroke with unknown time of onset
Neurol 95:e2954-e2964, Macha, K.,et al, 2020
Lesion Age Imaging in Acute Stroke: Water Uptake in CT Versus DWI-FLAIR Mismatch
Ann Neurol 88:1144-1152, Broocks, G.,et al, 2020
MRI-Guided Thrombolysis for Stroke with Unknown Time of Onset
NEJM 379:611-622, 682, Thomalla, G.,et al, 2018
Intravenous Thrombolysis in Unwitnessed Stroke Onset: MR WITNESS Trial Results
Ann Neurol 83:980-993, Schwamm, L.H.,et al, 2018
Spinal Cord Infarction Because of Spontaneous Vertebral Artery Dissection
Stroke 49:e314-e317, Montalvo, M.,et al, 2018
Clinicopathologic Conference, Cerebral Infarction from Internal Carotid Occlusion Related to Sickle Cell Arteriopathy
NEJM 374:1265-1275, Case 10-2016, 2016
A 76-Year-Old Man with Acute-Onset Left-Sided Weakness and Numbness
Neurol 86:e156-e160, Renthal, W.,et al, 2016
Treatment of Carotid Intramural Thrombus with TPA
JAMA Neurol 73:1496, Bennett, A.,et al, 2016
Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging Selection
NEJM 372:1009-1018, Campbell, B.C.V.,et al, 2015
Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke
NEJM 372:1019-1030, Goyal, M.,et al, 2015
Stent-Retriever Thrombectomy after Intravenous t-PA vs. t-PA Alone in Stroke
NEJM 372:2285-2295,2347, Saver, J.L.,et al, 2015
Thrombectomy within 8 hours after Symptom Onset in Ischemic Stroke
NEJM 372:2296-2306,2347, Jovin, T.G.,et al, 2015
Screening with MRI for Accurate and Rapid Stroke Treatment
Neurol 84:2438-2444, 2394, Shah, S.,et al, 2015
Microbleed Status and 3-Month Outcome After Intravenous Thrombolysis in 717 Patients with Acute Ischemic Stroke
Stroke 46:2458-2463,2403, Turc, G.,et al, 2015
Brush Sign on 3-T T2* - Weighted MRI as a Potential Predictor of Hemorrhagic Transformation After Tissue Plasminogen Activator Therapy
Stroke 45:274-276, Terasawa, Y.,et al, 2014
Preexisting Cerebral Microbleeds on Susceptibility-Weighted Magnetic Resonance Imaging and Post-Thrombolysis Bleeding Risk in 392 Patients
Stroke 45:1684-1688, Gratz, P.P.,et al, 2014
Number of Cerebral Microbleeds and Risk of Intracerebral Hemorrhage after Intravenous Thrombolysis
Stroke 45:2900-2905, Dannenberg, S.,et al, 2014
Endovascular Therapy after Intravenous t-PA versus t-PA Alone for Stroke
NEJM 368:893-903,952, Broderick, J.P.,et al, 2013
Negative Diffusion-Weighted Imaging After Intravenous Tissue-Type Plasminogen Activator is Rare and Unlikely to Indicate Averted Infarction
Stroke 44-1629-1634, Freeman, J.,et al, 2013
New Appearance of Extraischemic Microbleeds on T2*-Weighted Magnetic Resonance Imaging 24 Hours After Tissue-Type Plasminogen Activator Administration
Stroke 44:2776-2781, Kimura, K.,et al, 2013
Acute Stroke Imaging: What is Sufficient for Triage to Endovascular Therapies?
AJNR 33:790-792, Lev, M.H., 2012
A Pragmatic Approach Using Magnetic Resonance Imaging to Treat Ischemic Strokes of Unknown Onset Time in a Thrombolytic Trial
Stroke 43:2331-2335, Song, S.S.,et al, 2012
Diagnosis and Management of Cerebral Venous Thrombosis: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
Stroke 42:1158-1192, Saposnik,G.,et al, 2011
Multimodal Imaging Does Not Delay Intravenous Thrombolytic Therapy in Acute Stroke
AJNR 32:864-68, Salottolo, K.M.,et al, 2011
Prevalence of MRI-defined recent silent ischemia and associated bleeding risk with thrombolysis
Neurol 76:1288-1295, Tisserand, M.,et al, 2011
Safety of tPA in Stroke Mimics and Neuroimaging-Negative Cerebral Ischemia
Neurol 74:1340-1345, 1336, Chernyshev,O.Y., et al, 2010
Safety of Performing CT Angiography in Stroke Patients Treated With Intravenous Thrombolysis
JNNP 81:783-787, Aulick�,P., et al, 2010
Cost-Effectiveness of Multimodal CT for Evaluation Acute Stroke
Neurol 75:1678-1685, Young,K.C.,et al, 2010
Cost-Effectiveness of Patient Selection Using Penumbral-Based MRI for Intravenous Thrombolysis
Stroke 40:1710-1720, Earnshaw,S.R.,et al, 2009
Neuroimaging in Acute Posterior Cerebral Artery Infarction
The Neurologist 14:170-180, Finelli,P.F., 2008
Comparison of CT Perfusion and Angiography and MRI in Selecting Stroke Patients for Acute Treatment
Neurol 68:694-697, Wintermark,M.,et al, 2007
Evaluation of the Clinical-Diffusion and Perfusion-Diffusion Mismatch Models in DEFUSE
Stroke 38:1826-1830,1718, Lansberg,M.G.,et al, 2007
Role of CT Angiography in Thrombolysis Decision-Making for Patients with Presumed Seizure at Stroke Onset
Stroke 37:915-917, Sylaja,P.N.,et al, 2006
Is Penumbral Imaging Useful for Extending the Treatment Window for Intravenous Tissue Plasminogen Activator?
Ann Neurol 60:499-501, Fisher,M., 2006
Clinical and Imaging Predictors of Intracerebral Haemorrhage in Stroke Patients Treated with Intravenous Tissue Plasminogen Activator
JNNP 76:70-75, Derex,I.,et al, 2005
Safety and Efficacy of Intravenous Tissue Plasminogen Activator Stroke Treatment in the 3- to 6-Hour Window Using Multimodal Transcranial Doppler/MRI Selection Protocol
Stroke 36:602-606, Ribo,M., et al, 2005
Guidelines for the Early Management of Patients with Ischemic Stroke
Stroke 36:916-921, Adams,H.,et al, 2005
Perfusion-Weighted Imaging/Diffusion-Weighted Imaging Mismatch on MRI Can Now be Used to Select Patients for Recombinant Tissue Plasminogen Activator Beyond 3 Hours
Stroke 36:1099-1100, 1100, Zivin,J.A., 2005
Perfusion-Weighted Imaging/Diffusion-Weighted Imaging Mismatch on MRI Can Now Be Used to Select Patients for Recombinant Tissue Plasminogen Activator Beyond 3 Hours
Stroke 36:1098-1099,1100, Schellinger,P.D. &Fiebach,J.B., 2005
MRI Screening Before Standard Tissue Plasminogen Activator Therapy Is Feasible and Safe
Stroke 36:1939-1943, Kang,D.-W.,et al, 2005
Early MRI Findings in Patients Receiving Tissue Plasminogen Activator Predict Outcome: Insights into the Pathophysiology of Acute Stroke in the Thrombolysis Era
Ann Neurol 55:105-112, Chalela,J.A.,et al, 2004
Clinicopath Conf, Malignant Middle Cerebral Artery Infarction
NEJM 350:707-716, Case 5-2004, 2004
Magnetic Resonance Imaging Improves Detection of Intracerebral Hemorrhage Over Computed Tomography after Intra-Arterial Thrombolysis
Stroke 35:491-495, Greer,D.M.,et al, 2004